Technical Analysis for IMM - Immupharma Plc

Grade Last Price % Change Price Change
grade D 14.0 -0.18% -0.03
IMM closed up 2.0 percent on Friday, August 7, 2020, on 1.35 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical IMM trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish -0.18%
200 DMA Support Bullish -0.18%
Crossed Above 20 DMA Bullish -0.18%
Doji - Bearish? Reversal -0.18%
Outside Day Range Expansion -0.18%
Fell Below 20 DMA Bearish 1.82%
200 DMA Support Bullish 1.82%
50 DMA Resistance Bearish -1.06%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.06%
200 DMA Support Bullish -1.06%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ImmuPharma plc is a drug discovery and development company. The Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The Company has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company's drug candidate and is a treatment for lupus, and life threatening auto immune disease. The Company's treatment for cancer, IPP-204106, has completed a Phase I/IIa study in cancer patients in France. Its compound IPP-102199 for pain relief is designed as a non-addictive replacement for morphine and other opioids, and is in pre-clinical development. Its treatment for inflammatory and allergic disorders (IPP-201007) is in early stage development. Its compound IPP-203101 is an antibiotic against methicillin-resistant staphylococcus aureus (MRSA) and other infections. The Company's research operations are in France.
Medicine Medical Specialties Cancer Drug Discovery Autoimmune Diseases Infectious Diseases Pain Antibiotics Bacterial Diseases Healthcare Associated Infections Infections Staphylococcus Aureus

Is IMM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.292
52 Week Low 6.91
Average Volume 521,993
200-Day Moving Average 13.58
50-Day Moving Average 14.29
20-Day Moving Average 14.02
10-Day Moving Average 14.05
Average True Range 1.30
ADX 18.64
+DI 22.53
-DI 13.44
Chandelier Exit (Long, 3 ATRs ) 12.85
Chandelier Exit (Short, 3 ATRs ) 15.25
Upper Bollinger Band 15.86
Lower Bollinger Band 12.17
Percent B (%b) 0.5
BandWidth 26.36
MACD Line -0.04
MACD Signal Line -0.01
MACD Histogram -0.0307
Fundamentals Value
Market Cap 12.43 Million
Num Shares 886 Thousand
EPS -0.03
Price-to-Earnings (P/E) Ratio -467.50
Price-to-Sales 13402.26
Price-to-Book 666.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.51
Resistance 3 (R3) 16.56 15.78 16.09
Resistance 2 (R2) 15.78 15.15 15.75 15.96
Resistance 1 (R1) 14.90 14.76 14.51 14.85 15.82
Pivot Point 14.12 14.12 13.93 14.10 14.12
Support 1 (S1) 13.25 13.49 12.86 13.20 12.23
Support 2 (S2) 12.47 13.10 12.44 12.09
Support 3 (S3) 11.59 12.47 11.96
Support 4 (S4) 11.54